EP1501437A4
Low intensity light therapy for the manipulation of fibroblast-derived mammalian cells and collagen
Abstract
This record has no abstract on file.
Term
Term ended
Projected expiry passed 8 April 2023, 3.5 years ago.
- Priority
- Filed
- Published
- Projected expiry
- Today
43 sheets
Sheet 1 Sheet 2 Sheet 3 Sheet 4 Sheet 5 Sheet 6 Sheet 7 Sheet 8 Sheet 9 Sheet 10 Sheet 11 Sheet 12 Sheet 13 Sheet 14 Sheet 15 Sheet 16 Sheet 17 Sheet 18 Sheet 19 Sheet 20 Sheet 21 Sheet 22 Sheet 23 Sheet 24 Sheet 25 Sheet 26 Sheet 27 Sheet 28 Sheet 29 Sheet 30 Sheet 31 Sheet 32 Sheet 33 Sheet 34 Sheet 35 Sheet 36 Sheet 37 Sheet 38 Sheet 39 Sheet 40 Sheet 41 Sheet 42 Sheet 43
Every citation, both ways
| Document | Relation | Office | Cited during |
|---|---|---|---|
| WO0053114A1 | Cites | World Intellectual Property Organization (WIPO) | Examiner |
| WO0074782A1 | Cites | World Intellectual Property Organization (WIPO) | Search report |
| WO03001984A2 | Cites | World Intellectual Property Organization (WIPO) | Search report |
| EP0320080A1 | Cites | European Patent Office (EPO) | Search report |
| ENNINGA I C ET AL: "The wavelength dependence of u.v.-induced pyrimidine dimer formation, cell killing and mutation induction in human diploid skin fibroblasts.", CARCINOGENESIS NOV 1986 LNKD- PUBMED:3769130, vol. 7, no. 11, November 1986 (1986-11-01), pages 1829 - 1836, XP008123891, ISSN: 0143-3334 | Non-patent | – | Search report |
| See also references of WO 03086215A1 | Non-patent | – | Examiner |
109 members in 12 offices
Priority claims3
| Document | Office | Kind | Date |
|---|---|---|---|
| 119772 | United States of America | – | |
| 11977202 | United States of America | A | |
| 0310509 | United States of America | W |
Members109
| Document | Office | Kind | |
|---|---|---|---|
| WO0032121A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU1746600A | Australia | A | |
| WO0032121A9 | World Intellectual Property Organization (WIPO) | A9 | |
| US6283956B1 | United States of America | B1 | |
| US2002123746A1 | United States of America | A1 | |
| US2003004499A1 | United States of America | A1 | |
| US2003004556A1 | United States of America | A1 | |
| CA2452408A1 | Canada | A1 | |
| WO03001984A2 | World Intellectual Property Organization (WIPO) | A2 | |
| US2003023283A1 | United States of America | A1 | |
| CA2457590A1 | Canada | A1 | |
| WO03017824A2 | World Intellectual Property Organization (WIPO) | A2 | |
| US2003060811A1 | United States of America | A1 | |
| CA2465906A1 | Canada | A1 | |
| WO03039478A2 | World Intellectual Property Organization (WIPO) | A2 | |
| US2003129154A1 | United States of America | A1 | |
| WO03001984A3 | World Intellectual Property Organization (WIPO) | A3 | |
| US6629971B2 | United States of America | B2 | |
| WO03039478A3 | World Intellectual Property Organization (WIPO) | A3 | |
| CA2482934A1 | Canada | A1 | |
| WO03017824A3 | World Intellectual Property Organization (WIPO) | A3 | |
| WO03086215A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU2003220671A1 | Australia | A1 | |
| US6663659B2 | United States of America | B2 | |
| US6676655B2 | United States of America | B2 | |
| EP1411817A2 | European Patent Office (EPO) | A2 | |
| IL159579A0 | Israel | A0 | |
| KR20040048881A | Republic of Korea | A | |
| KR20040048888A | Republic of Korea | A | |
| EP1427482A2 | European Patent Office (EPO) | A2 | |
| IL160505A0 | Israel | A0 | |
| BR0212142A | Brazil | A | |
| BR0213996A | Brazil | A | |
| EP1453431A2 | European Patent Office (EPO) | A2 | |
| MXPA04000187A | Mexico | A | |
| MXPA04001710A | Mexico | A | |
| EP1501437A1 | European Patent Office (EPO) | A1 | |
| JP2005503388A | Japan | A | |
| CN1578688A | China | A | |
| MXPA04011187A | Mexico | A | |
| CN1602172A | China | A | |
| MXPA04004463A | Mexico | A | |
| US6887260B1 | United States of America | B1 | |
| JP2005512620A | Japan | A | |
| KR20050044388A | Republic of Korea | A | |
| JP2005521432A | Japan | A | |
| ZA200403664B | South Africa | B | |
| CN1658804A | China | A | |
| US6936044B2 | United States of America | B2 | |
| EP1427482A4 | European Patent Office (EPO) | A4 | |
| IL161865A0 | Israel | A0 | |
| US2005261750A1 | United States of America | A1 | |
| IL164644A0 | Israel | A0 | |
| EP1411817A4 | European Patent Office (EPO) | A4 | |
| BR0210739A | Brazil | A | |
| EP1453431A4 | European Patent Office (EPO) | A4 | |
| US2006129209A1 | United States of America | A1 | |
| US2006184214A1 | United States of America | A1 | |
| US2006200213A1 | United States of America | A1 | |
| US2006212025A1 | United States of America | A1 | |
| ZA200400477B | South Africa | B | |
| US7201765B2 | United States of America | B2 | |
| AU2007212519A1 | Australia | A1 | |
| CA2640203A1 | Canada | A1 | |
| US2007191822A1 | United States of America | A1 | |
| WO2007092349A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU2002326716B2 | Australia | B2 | |
| CA2644219A1 | Canada | A1 | |
| WO2007103132A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU2002320215B2 | Australia | B2 | |
| AU2002357695B2 | Australia | B2 | |
| AU2003220671B2 | Australia | B2 | |
| WO2007103132A3 | World Intellectual Property Organization (WIPO) | A3 | |
| WO2007092349A3 | World Intellectual Property Organization (WIPO) | A3 | |
| EP1986744A2 | European Patent Office (EPO) | A2 | |
| EP1991673A2 | European Patent Office (EPO) | A2 | |
| US7494503B2 | United States of America | B2 | |
| EP1986744A4 | European Patent Office (EPO) | A4 | |
| JP2009525141A | Japan | A | |
| JP2009528853A | Japan | A | |
| JP2010047590A | Japan | A | |
| US2010055789A1 | United States of America | A1 | |
| US2010121254A1 | United States of America | A1 | |
| US2010174222A1 | United States of America | A1 | |
| EP1501437A4This record | European Patent Office (EPO) | A4 | |
| US2010256550A1 | United States of America | A1 | |
| EP1991673A4 | European Patent Office (EPO) | A4 | |
| CA2452408C | Canada | C | |
| AU2007212519B2 | Australia | B2 | |
| AU2012200092A1 | Australia | A1 | |
| CA2465906C | Canada | C | |
| CN102343126A | China | A | |
| AU2007212519C1 | Australia | C1 | |
| CN1578688B | China | B | |
| IL161865A | Israel | A | |
| ZA200401528B | South Africa | B | |
| IL160505A | Israel | A | |
| KR101239925B1 | Republic of Korea | B1 | |
| US8651112B2 | United States of America | B2 | |
| US9017391B2 | United States of America | B2 |
Showing 100 of 109
14 legal events, as 2 offices reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | Office | |
|---|---|---|---|
| Application refused18R | 18R | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: THE APPLICATION HAS BEEN REFUSEDSTAA | STAA | EP | |
| Refusal decision now finalR003 | R003 | DE | |
| First examination report despatched17Q | 17Q | EP | |
| Supplementary search report drawn up and despatchedA4 | A4 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Party data changed (applicant data changed or rights of an application transferred)RAP1 | RAP1 | EP | |
| Party data changed (applicant data changed or rights of an application transferred)RAP1 | RAP1 | EP | |
| Party data changed (applicant data changed or rights of an application transferred)RAP1 | RAP1 | EP | |
| Request for examination filed17P | 17P | EP | |
| Designated contracting statesAK | AK | EP | |
| Request for extension of the european patentAX | AX | EP | |
| Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI | PUAI | EP |
Numbers
- Publication
- 1501437
- Application
- 37169927
Titles3
- German
- NIEDERINTENSITÄTS-LICHTTHERAPIE ZUR MANIPULATION VON SÄUGETIERZELLEN AUS FIBROBLASEN UND KOLLAGEN
- English
- LOW INTENSITY LIGHT THERAPY FOR THE MANIPULATION OF FIBROBLAST-DERIVED MAMMALIAN CELLS AND COLLAGEN
- French
- LUMINOTHERAPIE A FAIBLE INTENSITE POUR LA MANIPULATION DE FIBROBLASTES ET DE CELLULES DE MAMMIFERE DERIVEES DES FIBROBLASTES ET COLLAGENE
Classification
- CPC, 33
- A61K8/35
- A61B18/203
- A61B2018/00023
- A61B2018/00452
- A61B2018/0047
- A61B2018/00702
- A61B2018/00791
- A61K8/19
- A61K8/31
- A61K8/347
- A61K8/361
- A61K8/365
- A61K8/368
- A61K8/49
- A61K8/494
- A61K8/4953
- A61K8/498
- A61K8/67
- A61K8/671
- A61K8/676
- A61K8/678
- A61K41/0057
- A61K2800/58
- A61K2800/782
- A61K2800/81
- A61N5/0617
- A61N5/062
- A61N2005/0652
- A61Q19/08
- A61K41/0071
- A61B2090/395
- A61K8/9706
- A61K8/9789
- IPC, 7
- A61B18 18
- A61N5 06
- A61B18 00
- A61B18 20
- A61B19 00
- A61K41 00
- A61M37 00
Designated states27
- Contracting states, 27
- Austria
- Belgium
- Bulgaria
- Switzerland
- Cyprus
- Czechia
- Germany
- Denmark
- Estonia
- Spain
- Finland
- France
- United Kingdom
- Greece
- Hungary
- Ireland
- Italy
- Liechtenstein
- Luxembourg
- Monaco
- Netherlands (Kingdom of the)
- Portugal
- Romania
- Sweden
and 3 moreShow fewer
- Slovenia
- Slovakia
- Türkiye